World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer-MedSci.cn

World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer

Liu, Q

Liu, Q (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin 300020, Peoples R China.

GLOBAL MEDICAL GENETICS, 2020; 7 (3): 73

科室
- - 订阅+
  - 更多科室
工具
服务